期刊文献+

Cyclin D1和Survivin在乳腺癌及乳腺纤维腺瘤组织中的表达及临床意义 被引量:3

Expression and Significance of Cyclin D1 and Survivin in Carcinoma of the Breast and Fibroadenoma of the Breast
原文传递
导出
摘要 目的检测细胞周期蛋白Cyclin D1和凋亡抑制因子Survivin在乳腺癌中的表达,探讨其与乳腺癌的关系。方法采用免疫组化法检测40例乳腺癌组织、40例乳腺纤维腺瘤组织以及20例正常乳腺组织中Cyclin D1和Survivin的表达,并分析其临床病理意义。结果Cyclin D1和Survivin在乳腺癌组织中的阳性表达率分别为72.5%(29/40)和65.0%(26/40),在乳腺纤维腺瘤中的阳性表达率分别为27.5%(11/40)和25.0%(10/40),而在正常乳腺组织中无表达,在乳腺癌中的表达明显高于乳腺良性肿瘤及正常乳腺组织(P<0.01);Cyclin D1和Survivin的阳性表达与乳腺癌的病期、有无淋巴结转移密切相关(P<0.05),而与肿瘤大小无关(P>0.05);Cyclin D1的阳性表达和Survivin的阳性表达呈正相关。结论Cyclin D1和Survivin在乳腺良、恶性肿瘤及乳腺正常组织中的表达有明显的差异;其表达与乳腺癌的病期及淋巴结转移有关;Cyclin D1和Survivin的表达有相关性。 Objective To detect the expression of Cyclin D1 and Survivin in carcinoma of the breast, to approach the relation of them and carcinoma of the breast. Methods Elivision immunohistochem ical techhnique was used to assess the expressions of Cyclin D1 and Survivin in 40 cases of carcinoma of the breast ,40 cases of fibroadenoma of the breast and 20 cases of nomal breast tissues, to analyze clinical meaning. Results The positive rates of Cyclin D1 and Survivin in carcinoma of the breast are 72.5% (29/40)and 65% (26/40), the positive rates of Cyclin D1 and Survivin in fibroadenoma of the breast are 27.5% (11/40)和25% (20/40),but no expression in nomal breast tissues; the positive rates of Cyclin D1 and Survivin in carcinoma of the breast are highter than those in fibroadenoma of the breast and nomal breast tissues(P 〈 0.01 ) ; the positive expressions of Cyclin D1 and Survivin in carcinoma of the breast are concerned with stage and transfer of lymph node( P 〈0. 05 ), but no correlation with size of tumor (P 〉 0.05 ) ; the positive expressions of Cyelin D1 and Survivin in carcinoma of the breast offer direct correlation. Conclusion the expression of Cyclin D1 and Survivin have apparent difference in benign tumor of the breast, malignant tumor of the breast and nomal breast tissues; the expression are concerned with with stage and transfer of lymph node ;the detection of Cyclin D1 and Survivin in carcinoma of the breast can offer determinate studying found for its stage,prognosis assessment and biologic treat.
出处 《社区医学杂志》 2010年第5期1-3,共3页 Journal Of Community Medicine
关键词 Cyclin D1 SURVIVIN 乳腺癌 乳腺纤维腺瘤 Cyclin D1 Survivin Carcinoma of the Breast Fibroadenoma of the Breast
  • 相关文献

参考文献7

  • 1张宏艳,刘端祺,范萍,黄其敏,侯新燕,彭雁,矫健,吕楠.乳腺癌普查初步报道及资料分析[J].解放军医学杂志,2007,32(6):654-654. 被引量:49
  • 2Fu M,Wang C,Li Z,et al. CyclinD1 normal and abnormal functions [ J ]. Endocrinology, 2004,145 ( 8 ) :5439.
  • 3Carreras R, Alameda F, Mancebo G, et al. A study of Ki - 67, cerbB2 and cyclin - D1 expression in CIN - I, CIN -III and squamous cell carcinoma of the cervix [ J ]. Histol Histopathol,2007,22 (6) :587 -592.
  • 4Kallio Mj, Nieminen M, Eriksson JE. Human inhibitor of apoptosis protein (IAP) survivin Participates in regulation of chromosome segregation and mitotic exit[ J]. FASEB J,2001,15 (14) :2721 - 2723.
  • 5Li F,Ling X. Survivin study:An update of"What is the next wave" [ J ]. J Cellular Physiol, 2006,208 ( 3 ) :476 - 486.
  • 6Wolanin K, Magalska A, Mos oieniak G, et al. Curcumin affects components of the chromosomal passenger complex and induces mitotic catastrophe in apoptosis resistant Bcr - Abl - expressing cells [ J]. Mol Cancer,2006,4(7 ) :457 - 469.
  • 7Papapetropoulos A, Fulton D, Mahboubi K, et al. Angiopoietin - 1 inhibits endothelial cell apoptosis via the Akt/survivin pathway [ J]. J Biol Chem,2000,275 ( 13 ) :9102 - 9105.

共引文献48

同被引文献36

  • 1Stenner M, Klussmann JP. Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved[J]. Eur Arch Otorhinolaryngo1,2009,266:333-341.
  • 2Ambrosini G,Adida C,Altieri DC,et al. A novel anti-apoptosis gene, survivin,expressed in cancer and lymphoma[J]. Nat Med, 1997,3(8) :917- 921.
  • 3Li F, Ling X. Survivin study: an update of "what is the next wave"[J]. J Cell Physio1,2006,205:476-$6.
  • 4Asanuma H,Torigoe T,Kamiguchi K,et al. Survivin expression is regu- lated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells[J]. Cancer Research,2005,65 (23) : 11018-11025.
  • 5Choi KS,Lee TH,Jung MH. Ribozyme-mediated cleavage of the human Survivin Mrna and inhibition of antiapoptoyic function of Survivin in MCF-7 cells[J]. Cancer Gene Ther, 2003,10 (2) : 87-95.
  • 6Motkura T,Bloom T,Kim HG,et al. A novel cyclin encoded by a bell- linked candidate oncogene[J]. Nature, 1991,350(6318 ) : 512.
  • 7Chen CH,Shen J,Lee WJ,et al. Overexpression of cyclin D1 and c-Myc gene products in human primary epithelial ovarian cancer[J]. Int J Gynecol Cancer, 2005,15 (5) : 878-883.
  • 8Pignataro L,Capaccio P,Carboni N ,et al. p53 and cyclin D1 protein ex-pression in carcinoma of parotid gland[J]. Anticancer Res, 1998,18(2B) : 1287.
  • 9Zeng T,Yamamoto H,Bowen E,et al. Cell cycle control in isopro- terenol-induced murine salivary acinar cell proliferation [J]. Comp Biochem Physiol, 1996,115 (3) : 271-279.
  • 10Salvesen HB,Iversen OE,Akalen LA,et al. Prognostic significance of angiogenesis and ki-67,p53,and p21 expression:a population-based endometrial carcinoma study[J]. J Clin Onool, 1999,17:138-139.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部